Cryo-electron microscopy and mass spectrometry analyses have revealed that the tau filaments from the brains of patients with AD and CBD are extensively post-translationally modified by phosphorylation, methylation, acetylation and ubiquitination, while the interplay between these post-translational modifications of tau protein influences the structure of the tau filaments [4]. The gene discussed is MAPT; the disease is Alzheimer disease.